ArticleFrontiers in nutrition2025

The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn's disease: a cohort study.

Chen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.